| Antibiotics versus placebo in the treatment of women with uncomplicated cystitis: a meta-analysis of randomized controlled trials ME Falagas, IK Kotsantis, EK Vouloumanou, PI Rafailidis Journal of Infection 58 (2), 91-102, 2009 | 249 | 2009 |
| Airborne hydrogen peroxide for disinfection of the hospital environment and infection control: a systematic review ME Falagas, PC Thomaidis, IK Kotsantis, K Sgouros, G Samonis, ... Journal of Hospital Infection 78 (3), 171-177, 2011 | 196 | 2011 |
| Prognostic significance of PD-L1 expression on circulating tumor cells in patients with head and neck squamous cell carcinoma A Strati, G Koutsodontis, G Papaxoinis, I Angelidis, M Zavridou, ... Annals of Oncology 28 (8), 1923-1933, 2017 | 190 | 2017 |
| Medical management of gastric cancer: a 2017 update N Charalampakis, P Economopoulou, I Kotsantis, M Tolia, D Schizas, ... Cancer medicine 7 (1), 123-133, 2018 | 172 | 2018 |
| Diagnostic tumor markers in head and neck squamous cell carcinoma (HNSCC) in the clinical setting P Economopoulou, R De Bree, I Kotsantis, A Psyrri Frontiers in oncology 9, 827, 2019 | 150 | 2019 |
| The promise of immunotherapy in head and neck squamous cell carcinoma: combinatorial immunotherapy approaches P Economopoulou, I Kotsantis, A Psyrri ESMO open 1 (6), e000122, 2016 | 59 | 2016 |
| Liquid biopsy: an emerging prognostic and predictive tool in head and neck squamous cell carcinoma (HNSCC). Focus on circulating tumor cells (CTCs) P Economopoulou, I Kotsantis, E Kyrodimos, ES Lianidou, A Psyrri Oral oncology 74, 83-89, 2017 | 58 | 2017 |
| Special issue about head and neck cancers: HPV positive cancers P Economopoulou, I Kotsantis, A Psyrri International journal of molecular sciences 21 (9), 3388, 2020 | 52 | 2020 |
| Tumor microenvironment and immunotherapy response in head and neck cancer P Economopoulou, I Kotsantis, A Psyrri Cancers 12 (11), 3377, 2020 | 41 | 2020 |
| The role of CXCL13 and CXCL9 in early breast cancer E Razis, KT Kalogeras, I Kotsantis, GA Koliou, K Manousou, R Wirtz, ... Clinical Breast Cancer 20 (1), e36-e53, 2020 | 34 | 2020 |
| Systematic review of recurrent osteosarcoma systemic therapy I Gazouli, A Kyriazoglou, I Kotsantis, M Anastasiou, A Pantazopoulos, ... Cancers 13 (8), 1757, 2021 | 32 | 2021 |
| Checkpoint inhibitors in head and neck cancer: rationale, clinical activity, and potential biomarkers P Economopoulou, I Kotsantis, A Psyrri Current treatment options in oncology 17, 1-12, 2016 | 30 | 2016 |
| Patterns of response to immune checkpoint inhibitors in association with genomic and clinical features in patients with head and neck squamous cell carcinoma (HNSCC) P Economopoulou, M Anastasiou, G Papaxoinis, N Spathas, A Spathis, ... Cancers 13 (2), 286, 2021 | 22 | 2021 |
| HPV16 E6/E7 expression in circulating tumor cells in oropharyngeal squamous cell cancers: A pilot study P Economopoulou, G Koutsodontis, M Avgeris, A Strati, C Kroupis, ... PLoS One 14 (5), e0215984, 2019 | 20 | 2019 |
| The DNA damage response network in the treatment of head and neck squamous cell carcinoma A Psyrri, M Gkotzamanidou, G Papaxoinis, L Krikoni, P Economopoulou, ... ESMO open 6 (2), 100075, 2021 | 18 | 2021 |
| Prognostic significance of IGF-1 signalling pathway in patients with advanced non-small cell lung cancer I Kotsantis, P Economopoulou, A Psyrri, E Maratou, D Pectasides, ... Anticancer Research 39 (8), 4185-4190, 2019 | 18 | 2019 |
| Prognostic impact of indoleamine 2, 3-dioxygenase 1 (IDO1) mRNA expression on circulating tumour cells of patients with head and neck squamous cell carcinoma P Economopoulou, A Kladi-Skandali, A Strati, G Koytsodontis, ... ESMO open 5 (3), e000646, 2020 | 16 | 2020 |
| Clinical benefit of pazopanib in a patient with metastatic chondrosarcoma: a case report and review of the literature O Tsavaris, P Economopoulou, I Kotsantis, L Reppas, C Avgerinou, ... Frontiers in oncology 8, 45, 2018 | 15 | 2018 |
| Nivolumab-related lichen planus of the lip in a patient with head and neck cancer P Economopoulou, O Nicolatou-Galitis, I Kotsantis, A Psyrri Oral Oncology 104, 104623, 2020 | 14 | 2020 |
| Surrogates of immunologic cell death (ICD) and chemoradiotherapy outcomes in head and neck squamous cell carcinoma (HNSCC) P Economopoulou, G Koutsodontis, A Strati, E Kirodimos, E Giotakis, ... Oral Oncology 94, 93-100, 2019 | 14 | 2019 |
